New weekly shot aims to slow Alzheimer's – early safety trial underway
NCT ID NCT03748303
First seen Mar 27, 2026 · Last updated May 13, 2026 · Updated 8 times
Summary
This early study tested a weekly injection of allopregnanolone in 6 people with mild Alzheimer's or early memory loss. The main goal was to find a safe dose that works like the IV version. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DEMENTIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Southern California - Alzheimer Disease Research Center - Healthcare Consultation Center II
Los Angeles, California, 90033, United States
Conditions
Explore the condition pages connected to this study.